trending Market Intelligence /marketintelligence/en/news-insights/trending/HuaaskiDHwhME7JdhsXG7A2 content esgSubNav
In This List

Veritas Pharma CFO resigns; interim replacement named

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


Veritas Pharma CFO resigns; interim replacement named

David Alexander resigned as the CFO and a director of Veritas Pharma Inc.

The company appointed Peter McFadden to replace Alexander as CFO on an interim basis.

Veritas Pharma develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders.